CRISPR

CRISPR11-chd7

ID
ZDB-CRISPR-230612-1
Name
CRISPR11-chd7
Previous Names
None
Target
Sequence
5' - CTTCAACCCAGATTATGTGGAGG - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
ncu101 chd7
Expression
Gene expression in Wild Types + CRISPR11-chd7
No data available
Phenotype
Phenotype resulting from CRISPR11-chd7
No data available
Phenotype of all Fish created by or utilizing CRISPR11-chd7
Phenotype Fish Conditions Figures
head ccnk expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
head krt17 expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head reep1 expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
head clrn2 expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
head myh7 expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head nfatc2b expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
antigen processing and presentation of endogenous peptide antigen via MHC class I decreased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
head lsm8 expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head capgb expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image,  Fig. 4. with image from Hancock et al., 2026
head aplp2 expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head trim2b expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
head mphosph10 expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
pre-mRNA catabolic process decreased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
serotonin receptor signaling pathway increased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
G1/S transition of mitotic cell cycle decreased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
cell cycle checkpoint signaling decreased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
head rgra expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
head rdh5 expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head pkhd1l1.1 expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
striated muscle contraction decreased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
head tgm5l expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
DNA biosynthetic process decreased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
head mnx1 expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
protein neddylation decreased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
head gfi1ab expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
head slc7a2 expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head tas2r200.1 expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
head scinlb expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
phototransduction, visible light increased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
head nefla expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head adisspa expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
mitotic prometaphase decreased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
head dpp6a expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head chd7 expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image,  Fig. 4. with image from Hancock et al., 2026
head dkc1 expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head gpr37l1a expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
head scin expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
head c9 expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
estrogen receptor signaling pathway decreased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
GCN2-mediated signaling decreased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head phex expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
head adgra2 expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
head pdyn expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
head npas4a expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
swimming behavior decreased process quality, abnormal chd7ncu101/ncu101 high light intensity Fig. 6. with image from Hancock et al., 2026
sensory perception of sound decreased process quality, abnormal chd7ncu101/ncu101 acoustic radiation Fig. 6. with image from Hancock et al., 2026
head vcana expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
head gsx1 expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay decreased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head capga expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
calcium-mediated signaling decreased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
mitotic metaphase decreased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
head pcsk9 expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
head grk1a expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head myhz2 expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head pcyt1aa expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
SRP-dependent cotranslational protein targeting to membrane decreased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head crybb2 expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
Roundabout signaling pathway decreased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head qtman expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 2. with image from Hancock et al., 2026
swimming behavior decreased process quality, abnormal chd7ncu101/ncu101 acoustic radiation Fig. 6. with image from Hancock et al., 2026
head eif5b expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head ptn expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 3. with image from Hancock et al., 2026
head icn expression decreased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
rRNA processing decreased occurrence, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
head smc1a expression increased amount, abnormal chd7ncu101/ncu101 standard conditions Fig. 4. with image from Hancock et al., 2026
sensory perception of light stimulus decreased process quality, abnormal chd7ncu101/ncu101 high light intensity Fig. 6. with image from Hancock et al., 2026
pericardium increased size, abnormal chd7ncu101/ncu101 (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
swim bladder uninflated, abnormal chd7ncu101/ncu101 (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
visual learning process characteristic, abnormal chd7ncu101/ncu101 (TL) altered light dark cycle Fig. 4 with image from Hodorovich et al., 2023
lapillus decreased amount, abnormal chd7ncu101/ncu101 (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
startle response process characteristic, abnormal chd7ncu101/ncu101 (TL) acoustic radiation Fig. 2 with image,  Fig. 3 with image from Hodorovich et al., 2023
lapillus decreased size, abnormal chd7ncu101/ncu101 (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
embryonic cranial skeleton morphogenesis disrupted, abnormal chd7ncu101/ncu101 (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
cranium morphology, abnormal chd7ncu101/ncu101 (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
otolith morphology, abnormal chd7ncu101/ncu101 (TL) acoustic radiation Fig. 3 with image from Hodorovich et al., 2023
visual behavior process characteristic, abnormal chd7ncu101/ncu101 (TL) altered light dark cycle Fig. 4 with image from Hodorovich et al., 2023
whole organism decreased life span, abnormal chd7ncu101/ncu101 (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
otolith morphology, abnormal chd7ncu101/ncu101 (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
sagitta decreased amount, abnormal chd7ncu101/ncu101 (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
nonassociative learning disrupted, abnormal chd7ncu101/ncu101 (TL) acoustic radiation Fig. 2 with image from Hodorovich et al., 2023
pericardium increased size, abnormal chd7ncu101/+ (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
swim bladder uninflated, abnormal chd7ncu101/+ (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
lapillus decreased amount, abnormal chd7ncu101/+ (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
lapillus decreased size, abnormal chd7ncu101/+ (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
cranium morphology, abnormal chd7ncu101/+ (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
embryonic cranial skeleton morphogenesis disrupted, abnormal chd7ncu101/+ (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
whole organism decreased life span, abnormal chd7ncu101/+ (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
otolith morphology, abnormal chd7ncu101/+ (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
sagitta decreased amount, abnormal chd7ncu101/+ (TL) standard conditions Fig. 1 with image from Hodorovich et al., 2023
Citations